PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33439402-1	2021	Acetylcholinesterase (AChE), one of the major therapeutic strategies for the treatment of Alzheimer"s disease (AD) is to increase the acetylcholine (ACh) level in the brain by inhibiting the biological activity of AChE.	Acetylcholine	134-147	acetylcholinesterase (Cartwright blood group)	Homo sapiens	0-20	
33439402-1	2021	Acetylcholinesterase (AChE), one of the major therapeutic strategies for the treatment of Alzheimer"s disease (AD) is to increase the acetylcholine (ACh) level in the brain by inhibiting the biological activity of AChE.	Acetylcholine	134-147	acetylcholinesterase (Cartwright blood group)	Homo sapiens	22-26	
33439402-1	2021	Acetylcholinesterase (AChE), one of the major therapeutic strategies for the treatment of Alzheimer"s disease (AD) is to increase the acetylcholine (ACh) level in the brain by inhibiting the biological activity of AChE.	Acetylcholine	134-147	acetylcholinesterase (Cartwright blood group)	Homo sapiens	214-218	
33439402-1	2021	Acetylcholinesterase (AChE), one of the major therapeutic strategies for the treatment of Alzheimer"s disease (AD) is to increase the acetylcholine (ACh) level in the brain by inhibiting the biological activity of AChE.	Acetylcholine	22-25	acetylcholinesterase (Cartwright blood group)	Homo sapiens	0-20	
33439402-1	2021	Acetylcholinesterase (AChE), one of the major therapeutic strategies for the treatment of Alzheimer"s disease (AD) is to increase the acetylcholine (ACh) level in the brain by inhibiting the biological activity of AChE.	Acetylcholine	22-25	acetylcholinesterase (Cartwright blood group)	Homo sapiens	214-218